Preview Mode Links will not work in preview mode

Stay current on medical, surgical, and aesthetic dermatology developments with Dermatology Weekly, a podcast featuring news relevant to the practice of dermatology, and peer-to-peer interviews with Doctor Vincent A. DeLeo, who interviews physician authors from Cutis on topics such as psoriasis, skin cancer, atopic dermatitis, hair and nail disorders, cosmetic procedures, environmental dermatology, contact dermatitis, pigmentation disorders, acne, rosacea, alopecia, practice management, and more. Plus, resident discussions geared toward physicians in-training. Subscribe now.

The information in this podcast is provided for informational and educational purposes only.


Apr 22, 2021

This week, Amber Atwater, MD, the immediate past president of the American Contact Dermatitis Society, reviews some highlights from the meeting, which was held in March.

Dr. Atwater, associate professor of dermatology at Duke University, Durham, N.C., discusses the 2021 “Contact Allergen of the Year,” a chemical that has been linked to reactions associated with shin pads and is an emerging allergen that was the topic of a recent report in Dermatitis.

Joining Dr. Atwater, Raina Bembry, MD, a dermatitis fellow at Duke University, provides the results of a study of shoe allergens she presented at the meeting. which found that about 20% of shoe allergens are not detected with the current screening series. Dr. Atwater and Dr. Bembry are first and second authors of this paper, respectively; other authors are members of the North American Contact Dermatitis Group.

Dr. Atwater also reviews the results of a study on the potential role of expanded series patch testing in residual facial dermatitis in patients treated with dupilumab (which received the Gold Alexander A. Fisher Resident Award at the meeting), a study on patterns of contact allergy in Black and White patients in Philadelphia over 10 years (which received the Silver Fisher Resident Award), a study of contact dermatitis information on different social media sites, and results of NACDG patch test results from 2017 to 2018.

Dr. Atwater disclosed receiving the Pfizer Independent Grant for Learning & Change and consulting for Henke. Dr. Bembry had no disclosures.


*  *  *

You can find more of our podcasts at     

Email the show: